Otros idiomas Avecho Biotechnology Limited

Acciones

AVE

AU0000047441

Mercado cerrado - Australian S.E. Otros sitios de cotización 07:45:39 03/05/2024			Varia. Cinco días.	Varia. 1 de enero.
0,004 ^AUD	0,00 %		0,00 %	+14,29 %

14/03	Avecho seguirá adelante con el ensayo de fase III de un fármaco contra el insomnio	MT
07/03	Avecho Biotechnology obtiene la autorización ética para su ensayo de fase tres sobre el insomnio	MT

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Avecho Biotechnology Begins Patient Recruitment for Phase Three Anti-Insomnia Drug Trial	25/03
Avecho to Push Forward with Phase III Trial of Anti-Insomnia Drug	14/03
Avecho Biotechnology Secures Ethics Clearance for Phase Three Insomnia Trial	07/03
Avecho Biotechnology Limited Reports Earnings Results for the Full Year Ended December 31, 2023	29/02
Avecho Biotechnology Limited Reports Earnings Results for the Half Year Ended June 30, 2023	31/08/23
Avecho Biotechnology Achieves Two-Year Stability Milestone for CBD Capsule	22/06/23
US Patent Office Allows Avecho Biotechnology's Patent on 'Optimized' Manufacturing Method for Tocopheryl Phosphate Mixture	29/05/23
Avecho Biotechnology Signs Licensing Deal with Arthur Group for Development of Cancer Drugs	22/05/23
Avecho Biotechnology Begins Manufacturing for Oral Cannabidiol Capsules	17/05/23
Avecho Biotechnology Raises AU$2 Million Via Entitlement Offer; Shares Slip 20%	09/05/23
Avecho Biotechnology CEO optimistic about phase III insomnia CBD trial	04/04/23
Avecho Biotechnology Conducts Entitlement Offer to Raise $11 Million to Fund Pivotal Phase Iii Clinical Trial	03/04/23
Avecho Biotechnology Limited Auditor Raises 'Going Concern' Doubt	15/03/23
Avecho Biotechnology Limited Reports Earnings Results for the Full Year Ended December 31, 2022	27/02/23
Avecho Biotechnology Expands Research Partnership for Cannabidiol Medication	22/02/23
Avecho Biotechnology Limited Announces Ongoing Collaboration with Lambert Initiative	21/02/23
Athenex Pharmaceutical Division Submits Avecho's Vitamin K Injection to US FDA	12/01/23
Athenex Submits Avecho's Phytonadione to FDA Pre-IND	12/01/23
Avecho Biotechnology Secures Ethics Approval for Phase 3 Insomnia Trial	22/12/22
Avecho Biotechnology Limited Receives Ethics Approval for its Pivotal Phase III Clinical Trial Testing its Oral CBD Softgel Capsule for Insomnia	21/12/22

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Avecho Biotechnology Limited

Acciones

AVE

AU0000047441

Otros idiomas

Filtros